- 101. HYDROCEPH FETUS-DELIVER
- [ ] (UMLS (ICD9CM) C0156990) =Disease or Syndrome ;
| - 151. hydroxide
- [OH- anion, found in common basic reagents and in biological ion transport and pH gradient systems. ( CSP )] (UMLS (CSP) C0220853) =Element, Ion, or Isotope =anion;
oxide |
- 102. HYDROCEPHAL FETUS-UNSPEC
- [ ] (UMLS (ICD9CM) C0156989) =Disease or Syndrome ;
| - 152. HYDROXOCOBALAMIN
- [Injectable form of VITAMIN B 12 that has been used therapeutically to treat VITAMIN B 12 DEFICIENCY. ( MSH )] (UMLS (NCI) C0020316) =Organic Chemical; Pharmacologic Substance; Vitamin =[VT101] CYANOCOBALAMIN;
=HYDROXOCOBALAMIN ACETATE;
HYDROXOCOBALAMIN 1000 MCG/ML |
- 103. Hydrocephalic fetus causing disproportion
- [ ] (UMLS (ICD9CM) C0156988) =Finding ;
| - 153. Hydroxy
- [neutral chemical group -OH on larger molecules (alcohols); do not confuse with HYDROXIDE and HYROXYL RADICAL, which are themselves free molecules. ( CSP )] (UMLS (NCI) C0700307) =Inorganic Chemical ;
=chemical group;
|
- 104. hydrocephalus
- [excessive accumulation of cerebrospinal fluid within the cranium which may be a congenital or acquired disorder; hydrocephalus ex-vacuo refers to ventricular dilation that occurs as a result of brain substance loss from cerebral infarction and other conditions. ( CSP )] (UMLS (NCI) C0020255) =Disease or Syndrome =Infant, Newborn, Diseases;
Intracranial Hypertension;
CEREB DEGENERATION NOS;
congenital brain disorder =Dandy-Walker Syndrome;
Hydrocephalus, Normal Pressure;
| - 154. hydroxy compound
- [ ] (UMLS (CSP) C1692326) =Chemical Viewed Structurally
|
- 105. HYDROCODONE
- [A semisynthetic hydrogenated codeine derivative and opioid agonist with analgesic and antitussive effects. Hydrocodone primarily binds to and activates the mu-opioid receptor in the central nervous system (CNS). This leads to analgesia, euphoria, respiratory depression, miosis, decreased gastrointestinal motility, cough suppression and physical dependence. Hydrocodone is converted to hydromorphone by the cytochrome P450 enzyme CYP2D6. ( NCI )] (UMLS (NCI) C0020264) =Organic Chemical; Pharmacologic Substance ;
=[CN101] OPIOID ANALGESICS;
codeine;
[RE301] OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS;
=HYDROCODONE BITARTRATE;
HYDROCODONE POLISTIREX;
HYDROCODONE RESIN COMPLEX;
HYDROCODONE BITARTRATE;
HYDROCODONE POLISTIREX;
HYDROCODONE RESIN COMPLEX;
Hydrocodone 1 MG/ML;
HYDROCODONE 10 MG;
HYDROCODONE 7.5 MG;
HYDROCODONE 5 MG;
| - 155. hydroxy fatty acid
- [hydroxy substituted fatty acid; mycolic acids are hydroxy long chain fatty acids found in the cell walls of bacteria in the genera Mycobacterium, Nocardia, and Corynebacterium. ( CSP )] (UMLS (CSP) C0596739) =Lipid ;
=Fatty Acid;
|
- 106. Hydrocodone/Acetaminophen
- [A combination preparation of the analgesic acetaminophen and the semisynthetic opioid agonist hydrocodone with analgesic and antitussive activities. Acetaminophen exerts its analgesic activity by inhibiting prostaglandin synthesis while hydrocodone exerts its analgesic activity by binding to the mu-receptors in the central nervous system (CNS), thereby mimicking the effects of endogenous opioids. ( NCI )] (UMLS (NCI) C0717367) =Organic Chemical; Pharmacologic Substance ;
| - 156. hydroxyaminoacid
- [ ] (UMLS (CSP) C0596740) =Amino Acid, Peptide, or Protein ;
=aa;
=2-Amino-3-(5-hydroxy-1-H-indol-3-yl)propionic Acid;
hydroxyproline;
2-Amino-3-hydroxypropionic Acid;
THREONINE;
L-Phenylalanine, 4-hydroxy-;
|
- 107. HYDROCORTAMATE
- (UMLS (NCI) C0544368) =Steroid; Pharmacologic Substance; Hormone
| - 157. hydroxyanthranilate
- [ ] (UMLS (CSP) C0178697) =Organic Chemical; Hazardous or Poisonous Substance ;
|
- 108. HYDROCORTAMATE HYDROCHLORIDE
- (UMLS (NCI) C1445700) =Steroid; Pharmacologic Substance; Hormone
| - 158. Hydroxyaryl-Protein Kinase
- [Widely expressed by human RYK Gene (TYR Kinase Family), 604-aa 68-kDa (precursor) RYK Receptor-Like Tyrosine Kinase is a potential growth factor receptor protein tyrosine kinase, containing a WIF domain, that differs from other family members at a number of conserved residues in the activation and nucleotide binding domains. RYK does not appear to be regulated by phosphorylation in the activation segment and mediation of biological activity may occur by recruitment of a signaling-competent auxiliary protein. (NCI) ( NCI )] (UMLS (NCI) C0215512) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 109. HYDROCORTISONE ACETATE
- [The synthetic acetate salt form of hydrocortisone, a corticosteroid with anti-inflammatory and immunosuppressive properties. Hydrocortisone acetate initially binds to the cytoplasmic glucocorticoid receptor; then the receptor-ligand complex is translocated to the nucleus where it initiates the transcription of genes encoding for anti-inflammatory mediators, such as cytokines and lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes. ( NCI )] (UMLS (NCI) C0063077) =Steroid; Pharmacologic Substance ;
=(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione;
[OR900] DENTAL AND ORAL AGENTS, TOPICAL OTHER;
[OP300] ANTI-INFLAMMATORIES, TOPICAL OPHTHALMIC;
=HYDROCORTISONE ACETATE 0.5 %;
HYDROCORTISONE ACETATE 1 %WV;
HYDROCORTISONE ACETATE 10 MG;
HYDROCORTISONE ACETATE 10 MG/GM;
HYDROCORTISONE ACETATE 25 GM;
HYDROCORTISONE ACETATE 5 MG;
HYDROCORTISONE ACETATE 50 MG/ML;
HYDROCORTISONE ACETATE 25 MG;
HYDROCORTISONE ACETATE 10 %;
HYDROCORTISONE ACETATE 30 MG;
HYDROCORTISONE ACETATE 25 MG/ML;
HYDROCORTISONE ACETATE 15 MG;
HYDROCORTISONE ACETATE 2.5 %;
HYDROCORTISONE ACETATE 1 %;
| - 159. hydroxybenzoate
- [benzoic acid or its salts substituted by one or more hydroxy groups in any position on the benzene ring. ( CSP )] (UMLS (CSP) C0178698) =Organic Chemical =benzoate;
=salicylate;
|
- 110. Hydrocortisone Cypionate
- (UMLS (NCI) C0612688) =Steroid; Pharmacologic Substance ;
=(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione;
=HYDROCORTISONE CYPIONATE 10 MG/5ML | - 160. Hydroxycarbamide
- [ribonucleotide reductase inhibitor which thereby lowers intracellular dNTP pools and slows DNA replication and repair; used as antineoplastic, cell devision inhibitor, and possible chemotherapy for sickle cell anemia. ( CSP )] (UMLS (NCI) C0020402) =Organic Chemical; Pharmacologic Substance ;
=[AN300] ANTINEOPLASTICS, ANTIMETABOLITES;
[AN000] ANTINEOPLASTICS;
CARBAMIDE;
sickling inhibitor =(+-)-N-Hydroxy-N-(1-benzo[b]thien-2-ylethyl)-urea;
HYDROXYUREA 200 MG;
HYDROXYUREA 300 MG;
HYDROXYUREA 400 MG;
HYDROXYUREA 500 MG;
HYDROXYUREA 1000 MG |
- 111. Hydrocortisone Sodium Phosphate
- (UMLS (NCI) C0770559) HYDROCORTISONE SODIUM PHOSPHATE PREPARATION;
=Steroid; Pharmacologic Substance ;
=(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione;
=HYDROCORTISONE SODIUM PHOSPHATE 50 MG/ML;
| - 161. HYDROXYCHLOROQUINE
- [A substance that decreases immune responses in the body. It is used to treat some autoimmune diseases, and is being studied as a treatment for graft-versus-host disease. Hydroxychloroquine belongs to the family of drugs called antiprotozoals. ( NCI )] (UMLS (NCI) C0020336) =Organic Chemical; Pharmacologic Substance ;
=Antimalarials;
chloroquine =HYDROXYCHLOROQUINE SULFATE;
|
- 112. Hydrocortisone Used as a Placebo
- [Hydrocortisone used as a placebo in comparative studies. ( NCI )] (UMLS (NCI) C0281715) =Therapeutic or Preventive Procedure
| - 162. Hydroxychloroquine/Prednisone/Tacrolimus
- (UMLS (NCI) C1134593) =Therapeutic or Preventive Procedure ;
|
- 113. Hydrocortisone/Ketoconazole
- (UMLS (NCI) C0935705) =Therapeutic or Preventive Procedure
| - 163. hydroxycholanate
- [ ] (UMLS (CSP) C0598159) =Steroid; Pharmacologic Substance; Biologically Active Substance
|
- 114. Hydrodiuril
- (UMLS (NCI) C0700698) =Organic Chemical; Pharmacologic Substance ;
| - 164. hydroxycholesterol
- [cholesterol which is substituted by a hydroxy group in any position. ( CSP )] (UMLS (CSP) C0020339) =Steroid =(-)-Cholesterol;
|
- 115. hydrofluoric acid
- [Hydrofluoric acid. A solution of hydrogen fluoride in water. It is a colorless fuming liquid which can cause painful burns. ( MSH )] (UMLS (CSP) C0020274) =Hazardous or Poisonous Substance; Inorganic Chemical ;
=Acids, Noncarboxylic;
Fluorine Compounds;
Inactive Ingredient Preparations;
=[TN407] FLUORIDE;
HYDROFLUORIC ACID 42.6 MG;
HYDROFLUORIC ACID 7.1 MG;
HYDROFLUORIC ACID 729 MG;
HYDROFLUORIC ACID 0.17 %;
HYDROFLUORIC ACID 0.2 %;
HYDROFLUORIC ACID 0.28 % | - 165. hydroxyindole
- [ ] (UMLS (CSP) C0596741) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 116. hydrogel lenticular implantation
- [ ] (UMLS (CSP) C0599292) =Therapeutic or Preventive Procedure
| - 166. hydroxyindoleacetate
- [hydroxy substituted acetic acid derivatives of the heterocyclic compound indole; 5-hydroxyindoleacetic acid is a metabolite of the neurotransmitter serotonin, and secreted in large amounts by patients with carcinoid tumors. ( CSP )] (UMLS (CSP) C0178699) =Organic Chemical; Biologically Active Substance ;
=indoleacetate;
|
- 117. hydrogen bond
- [strong intermolecular forces produced by the attraction of a hydrogen atom, already covalently bonded to one electronegative atom, to a second electronegative atom of the same molecule or an adjacent molecule; these bonds are found in compounds containing strong electronegative atoms such as fluorine, oxygen, or nitrogen. ( CSP )] (UMLS (CSP) C0020276) =Natural Phenomenon or Process =chemical bond;
| - 167. hydroxyl radical
- [OH., a neutral, highly reactive, toxic free radical commonly found in biological systems. ( CSP )] (UMLS (CSP) C0063146) =Inorganic Chemical =free radical oxygen;
|
- 118. hydrogen channel
- [molecule-sized pores in biomembranes that permit the passage of hydrogen ions, and the proteins that form such pores and control their permeability; especially, a passage in the inner mitochondrial membrane that facilitates the movement of protons out of the mitochondrial matrix during oxidative phosphorylation. ( CSP )] (UMLS (CSP) C0596734) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Ion Channel;
| - 168. hydroxylamine
- [organic compounds that contain the -NH2OH radical. ( CSP )] (UMLS (CSP) C0020362) =Inorganic Chemical =amine;
=hydroxamate;
|
- 119. hydrogen electrode
- [ ] (UMLS (CSP) C0598355) =Manufactured Object ;
| - 169. hydroxylase
- [These enzymes use molecular oxygen catalyze the donation of one oxygen atom to a substrate specific site, while the other atom is donated to the generation of water. The enzyme uses molecular oxygen as the oxygen source instead of water, and is critical for several endocrine function operations. ( NCI )] (UMLS (CSP) C0020364) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 120. hydrogen fluoride
- [ ] (UMLS (CSP) C0520465) =Hazardous or Poisonous Substance; Inorganic Chemical ;
| - 170. hydroxylation
- [adding a hydroxyl group to a compound in a new position. ( CSP )] (UMLS (CSP) C0020365) =Natural Phenomenon or Process =chemical reaction;
=N hydroxylation;
|
- 121. hydrogen peroxide generating oxidase
- [nonEC. ( CSP )] (UMLS (CSP) C0897757) oxygen generating oxidase;
oxygen producing enzyme;
respiratory burst oxidase;
superoxide forming enzyme =Amino Acid, Peptide, or Protein; Enzyme ;
=NAD(P)H oxidoreductase;
| - 171. hydroxylysine
- [A hydroxylated derivative of the amino acid LYSINE that is present in certain collagens. ( MSH )] (UMLS (CSP) C0020366) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 122. hydrogen sulfide
- [toxic gas, H2S. ( CSP )] (UMLS (CSP) C0020282) =Indicator, Reagent, or Diagnostic Aid; Hazardous or Poisonous Substance; Inorganic Chemical =Acids, Noncarboxylic;
Gas;
sulfide;
sulfur compound =sulfide | - 172. hydroxyproline
- [C5H9NO3; amino acid derived from proline, found in collagen and gelatin. ( CSP )] (UMLS (CSP) C0020388) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Amino Acids, Cyclic;
hydroxyaminoacid |
- 123. hydrogen transport
- [movement of hydrogen ions (protons) across biological membranes; may be active, passive, or facilitated. ( CSP )] (UMLS (CSP) C0596735) =Cell Function ;
=biological transport;
| - 173. Hydroxyproline Urine Increased
- (UMLS (NCI) C1167655) =Finding
|
- 124. hydrogenase
- [specific enzyme (EC 1.18.99.1) that catalyzes the conversion of H+ to hydrogen gas via oxidation of ferredoxin; do not use for general term to cover other hydrogenating enzymes. ( CSP )] (UMLS (CSP) C0020284) =Amino Acid, Peptide, or Protein; Enzyme ;
=miscellaneous oxidoreductase;
| - 174. hydroxypyridine
- [ ] (UMLS (CSP) C0599260) =Organic Chemical ;
|
- 125. hydrogenation
- [Addition of hydrogen to a compound, especially to an unsaturated fat or fatty acid. (From Stedman, 26th ed) ( MSH )] (UMLS (CSP) C0020286) =Natural Phenomenon or Process
| - 175. hydroxysteroid
- [steroids in which one or more hydroxy groups have been substituted for hydrogen atoms either within the ring skeleton or on any of the side chains. ( CSP )] (UMLS (CSP) C0020393) =Steroid =oxysteroid;
=sterol;
|
- 126. hydrolase
- [Enzymes (EC class 3) cleaving substrates with addition of H2O at the point of cleavage; e.g., esterases, phosphatases, nucleases, peptidases. SYN hydrolyzing enzymes. ( NCI )] (UMLS (CSP) C0020289) =Amino Acid, Peptide, or Protein; Enzyme ;
=enzyme;
Enzymatic Agents =Ester Hydrolase;
glycosidase;
Enzymes, Proteolytic;
acid anhydride hydrolase;
carbon carbon hydrolase;
carbon nitrogen hydrolase;
ether hydrolase;
hepatic lipase;
amidinohydrolase;
aminohydrolase;
Ester Hydrolase;
glycosidase;
Pancreatin;
Enzymes, Proteolytic | - 176. hydroxysteroid dehydrogenase
- [Enzymes of the oxidoreductase class that catalyze the dehydrogenation of hydroxysteroids. (From Enzyme Nomenclature, 1992) EC 1.1.-. ( MSH )] (UMLS (CSP) C0020392) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol oxidoreductase;
|
- 127. Hydrolase Family Gene
- (UMLS (NCI) C1334064) Hydrolase Gene =Gene or Genome ;
| - 177. HYDROXYSTILBAMIDINE
- (UMLS (NCI) C0063195) =Organic Chemical; Pharmacologic Substance ;
|
- 128. hydrolysis
- [process of cleaving a chemical compound by the addition of a molecule of water. ( CSP )] (UMLS (NCI) C0020291) =Natural Phenomenon or Process =solvolysis;
| - 178. HYDROXYSTILBAMIDINE ISETHIONATE
- (UMLS (NCI) C0304340) =Organic Chemical; Pharmacologic Substance
|
- 129. HYDROMYELIA
- (UMLS (ICD9CM) C0152444) =Congenital Abnormality
| - 179. Hydroxytyrosol
- (UMLS (NCI) C0243264) =Organic Chemical; Pharmacologic Substance
|
- 130. hydronaphthalene
- [ ] (UMLS (CSP) C0596736) =Organic Chemical ;
| - 180. HYDROXYZINE
- [A piperazine derivative with antihistamine, antiemetic, and anxiolytic properties. Hydroxyzine's antihistaminic effect is due to its metabolite, cetirizine, a potent H1 receptor antagonist and selective inhibitor of peripheral H1 receptors. This agent competes with histamine for binding at H1-receptor sites on the effector cell surface. The sedative properties of hydroxyzine occur as a result of suppression of certain subcortical regions of the brain. Secondary to its central anticholinergic actions, hydroxyzine may be effective as an antiemetic. ( NCI )] (UMLS (NCI) C0020404) =Organic Chemical; Pharmacologic Substance ;
=Piperazines;
[AH500] ANTIHISTAMINES, PIPERAZINE =CETIRIZINE;
1-(p-Chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)diethylenediamine Hydrochloride;
2-Naphthoic Acid, 4,4'-methylenebis(3-hydroxy-, ester with 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)-ethoxy)ethanol;
1-(p-Chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)diethylenediamine Hydrochloride;
2-Naphthoic Acid, 4,4'-methylenebis(3-hydroxy-, ester with 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)-ethoxy)ethanol;
|
- 131. hydronaphthylamine
- [ ] (UMLS (CSP) C0598920) =Organic Chemical ;
| - 181. Hydrozoa
- [class in the phylum Cnidaria which alternates between polyp and medusa forms during their life cycle; there are over 2700 species in five orders. ( CSP )] (UMLS (CSP) C0178442) =Invertebrate ;
=Cnidaria;
|
- 132. hydronephrosis
- [distention of the pelvis and calices of the kidney with urine, as a result of obstruction of the ureter, with accompanying atrophy of the parenchyma of the organ. ( CSP )] (UMLS (NCI) C0020295) =Disease or Syndrome =Kidney Disease;
| - 182. Hygroton
- (UMLS (NCI) C0591623) =Organic Chemical; Pharmacologic Substance
|
- 133. hydropathy
- [tendency of a chemical compound or molecular domain to be included (hydrophilicity) or excluded (hydrophobicity) from aqueous solvents; important in protein folding, structure, and binding and biological membrane structure; do not use for hydrotherapy. ( CSP )] (UMLS (CSP) C0596737) =Quantitative Concept ;
=Chemical Properties;
| - 183. Hymen
- (UMLS (HL7) C0020412) =Body Part, Organ, or Organ Component =Body Part;
|
- 134. hydropericardium
- [ ] (UMLS (CSP) C0349077) =Pathologic Function
| - 184. HYMENECTOMY
- (UMLS (ICD9CM) C0195147) =Therapeutic or Preventive Procedure
|
- 135. Hydrophilic
- [The inherent characteristic of a molecule or substance to be soluble in water. ( NCI )] (UMLS (NCI) C0475370) =Quantitative Concept
| - 185. HYMENOLEPIASIS
- [Infection with tapeworms of the genus Hymenolepis. ( MSH )] (UMLS (ICD9CM) C0020413) =Disease or Syndrome =CESTODE INFECTION NOS;
|
- 136. hydrophobia
- [acute infectious disease of the central nervous system affecting almost all mammals, including humans; it is caused by a rhabdovirus and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals; important animal vectors include the dog, cat, vampire bat, mongoose, skunk, wolf, raccoon, and fox. ( CSP )] (UMLS (CSP) C0034494) =Disease or Syndrome =Infection, Viral;
Rhabdoviridae Infections;
nervous system infection;
| - 186. Hymenoptera
- [order of insects, including bees, wasps, and ants, characterized by high development of social or colonial behavior and usually by locked pairs of membranous wings. ( CSP )] (UMLS (CSP) C0020415) =Invertebrate =Insecta;
|
- 137. Hydrophobic
- [The inherent characteristic of a molecule or substance to be immiscible in water. The property means that the moiety of interest does not dissolve in, absorb, or mix easily with water. ( NCI )] (UMLS (NCI) C0598629) =Qualitative Concept ;
| - 187. HYMENORRHAPHY
- [ ] (UMLS (ICD9CM) C1536865) =Therapeutic or Preventive Procedure
|
- 138. Hydropic Change
- (UMLS (NCI) C0333442) =Pathologic Function
| - 188. HYMENOTOMY
- (UMLS (ICD9CM) C0195131) =Therapeutic or Preventive Procedure
|
- 139. Hydropic Villous Change
- (UMLS (NCI) C1334065) =Finding ;
| - 189. Hymorphan
- (UMLS (NCI) C0701971) =Organic Chemical; Pharmacologic Substance
|
- 140. Hydrops fetalis due to isoimmunization
- [ ] (UMLS (ICD9CM) C0455990) =Disease or Syndrome
| - 190. Hyoepiglottic Ligament
- [A short elastic band that unites the epiglottis to the upper border of the hyoid bone. ( NCI )] (UMLS (NCI) C0225515) =Body Part, Organ, or Organ Component
|
- 141. HYDROPS FETALIS NO ISOIM
- [ ] (UMLS (ICD9CM) C0455988) =Disease or Syndrome
| - 191. Hyoglossal Muscle
- (UMLS (NCI) C0224196) =Body Part, Organ, or Organ Component
|
- 142. HYDROPS OF GALLBLADDER
- (UMLS (ICD9CM) C0152445) =Disease or Syndrome
| - 192. Hyoid Arch
- (UMLS (NCI) C0231064) =Embryonic Structure
|
- 143. hydropyridine
- [ ] (UMLS (CSP) C0596738) =Organic Chemical ;
| - 193. Hyoid Bone
- (UMLS (NCI) C0020417) =Body Part, Organ, or Organ Component
|
- 144. hydrostatic pressure
- [pressure at any level on a fluid at rest due the weight of the fluid above it. ( CSP )] (UMLS (CSP) C0020309) =Natural Phenomenon or Process =Physical Phenomenon;
=intraocular pressure;
| - 194. Hyoid Muscle
- (UMLS (NCI) C0448345) =Body Part, Organ, or Organ Component
|
- 145. hydrotherapy
- [External application of water for therapeutic purposes. ( MSH )] (UMLS (CSP) C0020311) =Therapeutic or Preventive Procedure
| - 195. HYOU1
- [This gene plays in the regulation of cellular response to ischemic stress conditions. ( NCI )] (UMLS (NCI) C1333935) HYOU1 Gene;
Hypoxia Up-Regulated 1 Gene =Gene or Genome ;
|
- 146. hydrothorax
- [A collection of watery fluid in the pleural cavity. (Dorland, 27th ed) ( MSH )] (UMLS (CSP) C0020312) =Disease or Syndrome =Pleural Disease;
| - 196. HYP HRT DIS NOS W/O HF
- [ ] (UMLS (ICD9CM) C1135332) Unspecified hypertensive heart disease without heart failure =Disease or Syndrome ;
|
- 147. hydroureter
- [Abnormal enlargement of the ureter caused by any blockage that prevents urine from draining into the bladder. ( NCI )] (UMLS (NCI) C0521620) =Anatomical Abnormality ;
| - 197. HYP HT DIS NOS W HT FAIL
- [ ] (UMLS (ICD9CM) C1135333) Unspecified hypertensive heart disease with heart failure =Disease or Syndrome ;
|
- 148. hydroxalkylglutathione lyase
- [ ] (UMLS (CSP) C0598527) =Amino Acid, Peptide, or Protein; Enzyme
| - 198. HYP HT/KD NOS I-IV W HF
- [ ] (UMLS (ICD9CM) C0494575) =Disease or Syndrome ;
|
- 149. hydroxamate
- [ ] (UMLS (CSP) C0178696) =Organic Chemical =hydroxylamine;
=1-Amino-6,17-dihydroxy-7,10,18,21-tetraoxo-27-(n-acetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane;
| - 199. HYP HT/KD NOS ST V W HF
- [ ] (UMLS (ICD9CM) C0494576) =Disease or Syndrome ;
|
- 150. Hydroxamic Acids
- [A group of weak acids with the general chemical formula RC(=O)N(R')OH and antineoplastic and antimicrobial activities. Hydroxamic acids covalently bind to the zinc(II) ion in the active sites of matrix metalloproteinases (MMP), thereby inhibiting the action of MMPs, inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. (NCI04) ( NCI )] (UMLS (NCI) C0020314) =Organic Chemical =Hydroxy Acids;
Hydroxylamines =1-Amino-6,17-dihydroxy-7,10,18,21-tetraoxo-27-(n-acetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane;
2-Hydroxyamino-2-ethanal | - 200. HYP KID NOS W CR KID V
- [ ] (UMLS (ICD9CM) C0348860) =Disease or Syndrome
|
home
